RILUZOL PMCS 50mg tablets medication leaflet

N07XX02 riluzole • Nervous system | Other nervous system drugs

Riluzole is a medication used for the treatment of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease. It works by reducing the release of glutamate, a neurotransmitter that can be toxic to motor neurons in excess.

The medication is taken orally, as directed by a doctor, usually twice daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor liver function.

Patients should be aware of potential side effects, such as nausea, fatigue, or elevated liver enzyme levels. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, fatigue, and elevated liver enzyme levels. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about RILUZOL PMCS 50mg

Substance: riluzole

Date of last drug list: 01-07-2013

Commercial code: W58642007

Concentration: 50mg

Pharmaceutical form: tablets

Quantity: 100

Product type: generic

Prescription restrictions: X

Marketing authorisation

Manufacturer: PRO. MED. CS PRAHA A.S. - REPUBLICA CEHA

Holder: PRO. MED. CS PRAHA A.S. - REPUBLICA CEHA

Number: 9930/2017/07

Shelf life: 2 years